Research Leaders

  • Link to /sites/default/files/styles/research_leaders/public/Chernoff-2022-headshot.jpg?itok=QosRs3iB
    Cancer Center Director

    Jonathan Chernoff, MD, PhD

    Senior Vice President
    Stanley P. Reimann Chair in Oncology Research

    Jonathan Chernoff works with Temple University Health System and Temple University leadership to guide Fox Chase into the future of cancer care. A molecular oncologist and medical oncologist, he helps Fox Chase focus on areas that best leverage the institution’s strengths in scientific development.

  • Elizabeth Plimack MD, MS Professor, Department of Hematology/Oncology
    Deputy Director

    Elizabeth Plimack, MD, MS

    Professor, Department of Hematology/Oncology
    Director, Genitourinary Clinical Research
  • Robert Uzzo, MD, MBA, FACS. “The question this trial asked, for the first time is, ‘Can you give this medicine to people who have these tumors but that don’t have tuberous sclerosis, which is a far more common condition?’”
    President & CEO

    Robert Uzzo, MD, MBA, FACS

    Executive Vice President for Cancer Services – Temple University Health System
    Senior Associate Dean, Clinical Cancer Research – Lewis Katz School of Medicine at Temple University
    G. Willing "Wing" Pepper Chair in Cancer Research

Associate Directors

  • Link to /sites/default/files/styles/research_leaders/public/Edelman-Martin_640x860_1.jpg?itok=ISN1E2sB
    Translational Research

    Martin J. Edelman, MD

    Chair and Professor, Department of Hematology/Oncology
    Deputy Cancer Center Director for Clinical Research
    G. Morris Dorrance Jr. Chair in Medical Oncology

    Martin Edelman’s research focuses on interdisciplinary and multimodality treatment of lung cancer with the goal of translating laboratory observations into practical clinical trials. His role at Fox Chase is to facilitate interactions between laboratory and clinical investigators.

  • Link to /sites/default/files/styles/research_leaders/public/CarolynFang640x840_1.jpg?itok=4WnKWdUK
    Population Science

    Carolyn Y. Fang, PhD

    Professor, Cancer Prevention and Control

    Carolyn Y. Fang studies how psychosocial and behavioral factors influence cancer risk and outcomes, particularly in underserved populations. Her work has made significant contributions to informing evidence-based approaches for addressing cancer health disparities.

  • Link to /sites/default/files/styles/research_leaders/public/Golemis-EricaPictureOffice2017_640x860_0.jpg?itok=_1aZucmb
    System Integration

    Erica Golemis, PhD

    Deputy Chief Science Officer
    Professor, Molecular Therapeutics
    William Wikoff Smith Chair in Cancer Research

    As Associate Director for System Integration, Erica Golemis works with Fox Chase and Temple scientists to develop relationships that will lead Fox Chase into the future. As chair of the Department of Cancer and Cell Biology at the Lewis Katz School of Medicine, she focuses on identifying and supporting research synergies that advance cancer research and cancer care.

  • Link to /sites/default/files/styles/research_leaders/public/Gricoski-j_Img5774_0.jpg?itok=UaqftAJs
    Administration & Planning

    John Gricoski

    Vice President, Research Administration

    John Gricoski is responsible for administration of the center, including oversight of research operating and capital budgets, and laboratory space planning. He also manages the NCI Cancer Center Support Grant. Gricoski has an MBA in finance and is a licensed Pennsylvania CPA.

  • Link to /sites/default/files/styles/research_leaders/public/Camille-Ragin-640x860_0.jpg?itok=DROpz16j
    Diversity, Equity, and Inclusion (DEI)

    Camille Ragin, PhD, MPH

    Professor, Cancer Prevention and Control

    Camille Ragin’s research focuses on gene-environment interactions and cancer health disparities. Her work applies molecular biomarkers, genomics, and public health tools to cancer research in African American communities and African-descended populations worldwide.

  • Link to /sites/default/files/styles/research_leaders/public/Rall-G_DSC0427_640x860_0.png?itok=rKwWVrUf
    Education & Training

    Glenn F. Rall, PhD

    Chief Academic Officer
    Professor, Blood Cell Development and Function

    Rall focuses on the intersection of virology, immunology, and neurobiology. As associate director of education and training, Rall oversees all faculty affairs, as well as mentoring and education programs.

  • Link to /sites/default/files/styles/research_leaders/public/Skorski_640x860.jpg?itok=8wLLEn8K
    Fels Cancer Institute for Personalized Medicine

    Tomasz Skorski, MD, PhD, DSc

    Associate Director, Fox Chase Cancer Center
    Director, Fels Cancer Institute for Personalized Medicine
    Professor, Department of Cancer and Cellular Biology

    As director of the Fels Cancer Institute for Personalized Medicine at Temple, Tomasz Skorski oversees the planning, organization, and direction of the institute’s operations and programs. His lab focuses on determining of the role of DNA repair mechanisms in acute and chronic leukemias.

  • Link to /sites/default/files/styles/research_leaders/public/MargaretVonMehren640x860_0.jpg?itok=a9VAAxiz
    Clinical Research

    Margaret von Mehren, MD

    Chief, Division of Sarcoma Medical Oncology
    Vice Chair and Professor, Department of Hematology/Oncology
    Physician Director, Clinical Trials Office

    Margaret von Mehren’s research focuses on developmental therapeutics for sarcomas and gastrointestinal stromal tumors. Her work in this area informs her role as the associate director for clinical research, in which she oversees much of the clinical trials process at Fox Chase.

  • Dave Wiest
    Basic Science

    David Wiest, PhD

    Scientific Director of the Research Institute
    Professor, Nuclear Dynamics and Cancer Program

    In his role as scientific director, David Wiest oversees the overall direction of science research at the center. His lab explores the molecular basis for normal and malignant hematopoiesis, with a particular emphasis on T lymphocyte development. 

  • Charnita Zeigler-Johnson
    Community Outreach and Engagement (COE)

    Charnita Zeigler-Johnson, PhD, MPH

    Charnita Zeigler-Johnson works with community partners as well as cancer center leadership and clinical chairs to address the needs of the communities that Fox Chase serves. She also integrates community-engaged research across scientific programs at Fox Chase and Temple Health.

Research Program Leaders

  • Link to /sites/default/files/styles/research_leaders/public/MargieClapper640x860.jpg?itok=H9z-7mUV
    Cancer Prevention and Control Program

    Margie L. Clapper, PhD

    Co-Leader, Cancer Prevention and Control
    Professor
    Samuel M.V. Hamilton Chair in Cancer Prevention

     

  • Link to /sites/default/files/styles/research_leaders/public/Hall_Michael_0.jpg?itok=AgSS0zKm
    Cancer Prevention and Control Program

    Michael J. Hall, MD, MS

    Chair and Professor, Department of Clinical Genetics
    Director, Gastrointestinal Risk Assessment
    Co-Leader, Cancer Prevention and Control Program

     

  • Link to /sites/default/files/styles/research_leaders/public/Edna_Cukierman_2019_640x860_0.jpg?itok=f7S1AzlC
    Cancer Signaling and Microenvironment Program

    Edna (Eti) Cukierman, PhD

    Co-Leader, Cancer Signaling and Epigenetics Program
    Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
    Co-Director, Immune Monitoring Facility

     

  • Neil Johnson, PhD
    Nuclear Dynamics and Cancer Program

    Neil Johnson, PhD

    Co-leader and Professor, Nuclear Dynamics and Cancer Program
    Co-Director, Biological Imaging Facility
  • Link to /sites/default/files/styles/research_leaders/public/Karanicolas-John-5_640x860.jpg?itok=td55kTyA
    Cancer Signaling and Microenvironment Program

    John Karanicolas, PhD

    Co-Leader and Professor, Cancer Signaling and Microenvironment Program

     

  • Link to /sites/default/files/styles/research_leaders/public/Whetstine-Johnathan-PhD-640x860.png?itok=ZYG17qAh
    Nuclear Dynamics and Cancer Program

    Johnathan R. Whetstine, PhD

    Co-Leader and Professor, Nuclear Dynamics and Cancer Program
    Director, Cancer Epigenetics Institute
    Jack Schultz Chair in Basic Science